查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1560967

2024-2032 年按产品、来源、应用、最终用户和地区分類的生物外科市场报告

Biosurgery Market Report by Product, Source, Application, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3个工作天内

价格

2023年，全球生物外科IMARC Group规模达139亿美元。该市场的推动因素包括越来越多的外科手术、医疗设备的技术进步以及复杂手术中对有效伤口管理不断增长的需求，这正在提高全球患者的手术效果和恢復时间。

生物外科市场分析：

  • 主要市场驱动力：慢性病盛行率的增加和人口老化是生物外科市场的主要驱动力，因为它们需要先进的外科干预和伤口护理解决方案。此外，生物材料和外科技术的技术进步也透过提高外科手术的有效性和安全性来推动市场成长。
  • 主要市场趋势：微创外科手术的趋势不断增长，这增加了对支持快速恢復和减少术后併发症的生物外科产品的需求。此外，对个人化医疗和标靶治疗的日益关注正在影响针对个别患者需求的生物外科产品的开发。
  • 地理趋势：由于其先进的医疗基础设施和新技术的高采用率，北美在生物外科市场中占有重要份额。此外，由于医疗保健投资的增加、意识的提高和患者人数的增加，亚太地区的市场正在经历快速成长。
  • 竞争格局：一些领先的生物外科公司包括 B. Braun Melsungen AG、Baxter International Inc.、Becton Dickinson and Company、CryoLife Inc.、CSL Limited、Hemostasis LLC、Integra Lifesciences Holdings Corporation、Johnson & Johnson、Medtronic plc、Pfizer Inc .、赛诺菲SA、Smith & Nephew plc、Stryker Corporation 和Surgalign Spine Technologies Inc. 等。
  • 挑战与机会：生物外科市场的主要挑战是先进生物外科产品的高成本，这可能限制在成本敏感地区的采用。此外，还有开发具有成本效益的解决方案和扩展到新兴市场的重大机会，这些市场不断提高的医疗保健标准带来了新的成长潜力。

生物外科市场趋势：

外科手术数量不断增加

全球外科手术的持续增加对生物外科市场产生了重大影响。根据美国国立卫生研究院（NIH）统计，2017年对980万例住院重大手术进行分析发现，11.1%涉及微创手术（MIS），2.5%使用机器人辅助。相较之下，2018 年进行的 960 万例住院手术中，11.2% 是 MIS，2.9% 是机器人辅助。此外，门诊MIS 手术的比例也逐年增长，从2016 年的16.9% 增加到2018 年的18%。安全、更容易。人口老化和对提高生活品质的更加重视导致了这一增长。随着手术量的增加，对减少併发症和改善疗效至关重要的生物外科产品的需求也在增加。密封剂、止血剂和黏合剂等产品越来越多地用于确保更好的恢復并最大限度地降低术中风险，从而创造了积极的生物外科市场前景。

慢性病增加

心血管疾病、糖尿病和癌症等慢性疾病的盛行率不断上升，是生物外科市场的另一个关键驱动力。美国疾病管制与预防中心指出，60% 的美国成年人患有至少一种慢性疾病，其中许多需要手术介入。据美国慢性病主任协会称，美国疾病预防控制中心 (CDC) 报告称，美国每年 3.8 兆美元的医疗保健支出中，90% 与患有慢性病和精神健康问题的个人有关。例如，心臟病和中风是美国的主要原因，每年夺走超过 944,800 人的生命，占所有死亡人数的三分之一以上。此外，预计到 2050 年，与心血管疾病相关的费用将达到 2 兆美元。随着慢性病发病率持续增加，对创新生物外科解决方案的需求加剧，鼓励公司开发和完善满足复杂医疗需求的技术，从而增加生物外科市场的整体收入。

运动伤害发生率上升

体育参与度和体育活动热情的增加导致运动相关伤害的发生率更高，这进一步影响了生物外科的市场价值。根据约翰霍普金斯大学医学报告，美国每年发生超过 350 万起运动伤害。在体育或娱乐活动造成的所有头部受伤中，近 50% 是由涉及自行车、滑板或溜冰鞋的事故造成的。此外，每年有超过 775,000 名 15 岁以下儿童到急诊室寻求运动相关伤害的照护。这些伤害通常是由于非官方体育赛事或休閒体育赛事期间的跌倒、碰撞和过度劳累造成的。此外，一些运动伤害，包括韧带撕裂和关节脱位，需要使用生物外科产品的外科手术来促进快速有效的復健。此外，在运动医学中，这些产品对于加速康復和让运动员恢復最佳状态至关重要。随着业余和专业水平对运动的兴趣持续增长，需要手术干预的损伤的频率将增加对该领域专门为运动相关治疗而设计的生物外科设备的需求。

生物外科市场细分：

IMARC Group提供了每个细分市场的主要趋势的分析，以及 2024-2032 年全球、区域和国家层面的预测。我们的报告根据产品、来源、应用和最终用户对市场进行了分类。

按产品划分：

  • 骨移植替代品
  • 软组织附件
  • 止血剂
  • 手术密封剂和黏合剂
  • 黏附屏障
  • 订书钉线加固

骨移植替代品占大部分市场份额

该报告根据产品提供了详细的市场细分和分析。这包括骨移植替代品、软组织附着物、止血剂、手术密封剂和黏合剂、黏连屏障和缝线加固。根据该报告，骨移植替代品占最大部分。

骨移植替代品是骨移植的重要替代方案。这些替代品在许多外科手术中发挥关键作用，支持骨科、创伤、脊椎手术和牙科应用中的骨再生和修復。它们的目的是透过促进骨骼发育和取代传统的自体移植物来最大程度地降低供体部位发病和感染的风险，传统的自体移植需要从患者自己的身体中取出骨骼。此外，骨骼和关节问题日益频繁、对侵入性较小的手术的需求以及生物材料技术的发展也推动了这种扩张。此细分市场的成长也得益于具有改进的骨传导和骨诱导品质的新型合成和复合移植物的创造。例如，2023 年 5 月 23 日，Royal Biologics, Inc. 是一家专注于先进细胞和自体技术以改善手术结果的公司，推出了 BIO-REIGN 3D。这种创新的骨移植替代品是第一个使用天然超交联碳水化合物聚合物的产品。它旨在增强骨移植手术，这项专有技术是与 Royal Biologics 就 Molecular Matrix 专利 Osteo-P BGS 技术的授权协议一起推出的。

按来源划分：

  • 天然/生物製品
  • 合成产品

天然/生物製品占据产业最大份额

报告还根据来源提供了详细的市场细分和分析。这包括天然/生物製品和合成产品。报告称，天然/生物製品占据最大的市场份额。

根据生物外科市场概况，天然/生物製剂因其有效的治疗特性和生物相容性而代表了最大的部分。这些产品源自于人体或其他生物来源中天然存在的物质，包括纤维蛋白密封剂、胶原蛋白基质和壳聚醣溶液。此外，天然/生物製剂产品模仿自然生理过程的能力显着降低了排斥和不良反应的风险，使其成为外科手术中的首选。此外，生物技术的进步进一步增强了这些材料的安全性和有效性，从而进一步支持了市场主导地位。因此，对微创手术的需求不断增长，加上需要复杂手术的慢性疾病的盛行率不断上升，继续推动市场上天然/生物製品的成长。

按应用划分：

  • 骨科手术
  • 一般外科
  • 神经外科
  • 心血管外科
  • 妇科手术
  • 其他的

神经外科代表领先的细分市场

该报告根据应用程式提供了详细的市场细分和分析。这包括骨科手术、一般外科、神经外科、心血管外科、妇科手术等。根据该报告，神经外科手术占最大部分。

神经外科手术非常复杂，并且需要严格的精确度。此外，生物外科产品，如封闭剂、止血剂和沾黏屏障，广泛用于神经手术中以控制出血、密封组织并减少术后併发症。此外，脑肿瘤、癫痫和帕金森氏症等神经系统疾病的盛行率不断上升，加上神经外科技术的进步，使得这一领域的需求不断增加。此外，微创（MI）手术的广泛采用需要高效的生物外科解决方案来提高患者的治疗效果，这进一步推动了生物外科市场的成长。这一趋势得到了生物外科产品技术创新的支持，旨在改善手术结果并缩短恢復时间。

按最终用户划分：

  • 医院
  • 诊所
  • 其他的

医院在市场上表现出明显的主导地位

报告还提供了基于最终用户的详细市场细分和分析。这包括医院、诊所和其他。报告显示，医院占据了最大的市场。

医院提供各种经常使用生物外科产品的外科手术。这些产品包括止血剂、手术密封剂和黏合剂，对于控制术中和术后出血以及促进组织癒合至关重要。此外，医院处理大量患者和进行复杂手术的能力增加了生物外科的需求。此外，手术技术的不断进步和对微创手术的日益偏好进一步扩大了生物外科解决方案在医院环境中的使用率。

按地区划分：

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

北美市场领先，占据最大的生物外科市场份额

该报告还对所有主要区域市场进行了全面分析，其中包括北美（美国和加拿大）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告称，北美是生物外科最大的区域市场。

北美因其先进的医疗基础设施、对研发 (R&D) 活动的大量投资以及推动创新和扩张的领先企业的存在而成为领先地区。此外，北美慢性病盛行率的增加和老年人口的增加导致对生物外科产品的需求增加。根据生物外科市场预测，这些因素加上有利的政府政策和微创手术的强劲趋势，将继续加强北美在全球生物外科市场的领先地位。

（请注意，这只是关键参与者的部分列表，报告中提供了完整列表。）

  • 目前，生物外科市场参与者正在透过策略合作、创新产品发布和新地域市场扩张等相结合的方式积极促进市场成长。这些公司在研发 (R&D) 方面投入巨资，推出先进产品，满足微创手术和改善伤口护理日益增长的需求。此外，市场参与者正专注于获得不同地区的监管批准，这有助于扩大其全球足迹并进入新市场。这些策略共同促进了生物外科市场的强劲成长和弹性。例如，2023 年，AROA Biosurgery Ltd. 发布了一个新的回顾性试验案例係列，探索使用 Myriad Matrix 和 Myriad Morcells 对受污染的体积软组织缺损进行手术治疗。它在一家机构检查了 10 名患者的 13 处复杂创伤伤口。研究报告实现软组织覆盖和填充的平均时间为 23.4+-9.2 天，平均使用一次产品，参与者没有出现併发症。此外，研究的重点是美国一级创伤中心的机动车事故损伤、疝气修復后的腹部裂开、福尼尔坏疽、筋膜室症候群和压力性损伤。结果发现，Myriad 产品促进了有效的软组织形成，并且没有报告併发症，从而增强了 AROA ECM 产品在创伤护理中的实用性。

生物外科市场新闻：

  • 2023 年 11 月，强生医疗科技公司 Ethicon 宣布批准 ETHIZIA，这是一种止血解决方案，可在挑战性情况下有效、持久地控制严重出血。这种新型止血贴片增强了 Ethicon 广泛的生物外科产品系列，并增强了其满足出血控制紧急需求的能力。

本报告回答的关键问题：

  • 迄今为止，全球生物外科市场表现如何，未来几年将如何表现？
  • 全球生物外科市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球生物外科市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的生物外科市场？
  • 基于产品的市场区隔是什么？
  • 生物外科市场上最具吸引力的产品是什么？
  • 依来源划分市场是怎么样的？
  • 哪个是生物外科市场中最具吸引力的来源？
  • 基于应用程式的市场区隔是什么？
  • 生物外科市场中哪一个应用最有吸引力？
  • 基于最终用户的市场区隔是什么？
  • 哪个是生物外科市场中最具吸引力的最终用户？
  • 市场竞争结构如何？
  • 谁是全球生物外科市场的主要参与者/公司？

本报告回答的关键问题：

  • 迄今为止，全球生物外科市场表现如何，未来几年将如何表现？
  • 全球生物外科市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球生物外科市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的生物外科市场？
  • 基于产品的市场区隔是什么？
  • 生物外科市场上最具吸引力的产品是什么？
  • 基于来源的市场区隔是什么？
  • 哪个是生物外科市场中最具吸引力的来源？
  • 基于应用程式的市场区隔是什么？
  • 生物外科市场中哪一个应用最有吸引力？
  • 基于最终用户的市场区隔是什么？
  • 哪个是生物外科市场中最具吸引力的最终用户？
  • 市场竞争结构如何？
  • 全球生物外科市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球生物外科市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品

  • 骨移植替代品
    • 市场趋势
    • 市场预测
  • 软组织附件
    • 市场趋势
    • 市场预测
  • 止血剂
    • 市场趋势
    • 市场预测
  • 手术密封剂和黏合剂
    • 市场趋势
    • 市场预测
  • 黏附屏障
    • 市场趋势
    • 市场预测
  • 订书钉线加固
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：依来源分类

  • 天然/生物製品
    • 市场趋势
    • 市场预测
  • 合成产品
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：按应用

  • 骨科手术
    • 市场趋势
    • 市场预测
  • 一般外科
    • 市场趋势
    • 市场预测
  • 神经外科
    • 市场趋势
    • 市场预测
  • 心血管外科
    • 市场趋势
    • 市场预测
  • 妇科手术
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：按最终用户

  • 医院
    • 市场趋势
    • 市场预测
  • 诊所
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 10 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • B. Braun Melsungen AG
    • Baxter International Inc.
    • Becton Dickinson and Company
    • CryoLife Inc.
    • CSL Limited
    • Hemostasis LLC
    • Integra Lifesciences Holdings Corporation
    • Johnson & Johnson
    • Medtronic plc
    • Pfizer Inc.
    • Sanofi SA
    • Smith & Nephew plc
    • Stryker Corporation
    • Surgalign Spine Technologies Inc.
Product Code: SR112024A4522

The global biosurgery market size reached US$ 13.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 24.1 Billion by 2032, exhibiting a growth rate (CAGR) of 6.1% during 2024-2032. The market is driven by the increasing surgical procedures, technological advancements in medical devices, and growing demand for effective wound management in complex surgeries, which is enhancing surgical outcomes and recovery times for patients across the globe.

Biosurgery Market Analysis:

  • Major Market Drivers: The increasing prevalence of chronic diseases and the aging population are major drivers for the biosurgery market, as they necessitate advanced surgical interventions and wound care solutions. Moreover, technological advancements in biomaterials and surgical techniques are also driving market growth by enhancing the effectiveness and safety of surgical procedures.
  • Key Market Trends: There is a growing trend toward minimally invasive surgical procedures, which is escalating the demand for biosurgical products that support quick recovery and reduced post-operative complications. Besides, increased focus on personalized medicine and targeted therapies are influencing the development of biosurgical products tailored to individual patient needs.
  • Geographical Trends: North America holds a significant share of the biosurgery market due to its advanced healthcare infrastructure and high adoption rates of new technologies. Moreover, the markets in Asia-Pacific are experiencing rapid growth due to rising healthcare investments, increasing awareness, and a growing patient population.
  • Competitive Landscape: Some of the leading biosurgery companies include B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, CryoLife Inc., CSL Limited, Hemostasis LLC, Integra Lifesciences Holdings Corporation, Johnson & Johnson, Medtronic plc, Pfizer Inc., Sanofi S.A., Smith & Nephew plc, Stryker Corporation and Surgalign Spine Technologies Inc., among many others.
  • Challenges and Opportunities: The major challenge in the biosurgery market is the high cost of advanced biosurgical products, which can limit adoption in cost-sensitive regions. Moreover, there are significant opportunities for developing cost-effective solutions and expanding into emerging markets, where rising healthcare standards present new growth potential.

Biosurgery Market Trends:

The Growing Number of Surgical Procedures

The consistent increase in surgical procedures globally significantly impacts the biosurgery market. As reported by the National Institutes of Health (NIH) statistics, in 2017, an analysis of 9.8 million major inpatient surgical procedures revealed that 11.1% involved minimally invasive surgery (MIS) and 2.5% utilized robotic assistance. This compares to the 9.6 million inpatient surgeries performed in 2018, where 11.2% were MIS and 2.9% were robotic assisted. Additionally, the percentage of ambulatory MIS procedures also grew annually, from 16.9% in 2016 to 18% in 2018.. This uptick is largely driven by advancements in medical technology and surgical techniques, which have made surgeries safer and more accessible. An aging population and a greater focus on enhancing quality of life contribute to this increase. As surgical volumes grow, the demand for biosurgery products, essential for reducing complications and improving outcomes, also increases. Products such as sealants, hemostatic agents, and adhesives are increasingly used to ensure better recovery and minimize intraoperative risks, thereby creating a positive biosurgery market outlook.

Increase in Chronic Diseases

The escalating prevalence of chronic diseases such as cardiovascular conditions, diabetes, and cancer is another pivotal driver for the biosurgery market. The Centers for Disease Control and Prevention notes that 60% of U.S. adults suffer from at least one chronic disease, many of which necessitate surgical interventions. According to the National Association of Chronic Disease Directors, the CDC reports that 90% of the annual $3.8 Trillion healthcare expenditure in the U.S. is linked to individuals with chronic illnesses and mental health conditions. For instance, heart disease and stroke are the leading causes of death in the United States, claiming over 944,800 lives annually, which accounts for more than one-third of all deaths. Furthermore, it is projected that the costs associated with cardiovascular diseases will reach $2 Trillion by 2050. Additionally, surgical interventions often include the use of biosurgery products to manage blood loss, repair tissues, and promote healing, particularly in complex procedures. As the incidence of chronic diseases continues to increase, the demand for innovative biosurgery solutions intensifies, encouraging companies to develop and refine technologies that cater to complex medical needs, thus increasing the overall biosurgery market revenue.

Rising Incidence of Sports Injuries

The increase in sports participation and enthusiasm for physical activities has led to a higher incidence of sports-related injuries, which is further influencing the biosurgery market value. According to a John Hopkins Medicine report, in the United States (US) over 3.5 million sports injuries occur each year. Almost 50% of all head injuries from sports or recreational activities are the result of incidents involving bicycles, skateboards, or skates. In addition, more than 775,000 kids under the age of 15 seek care for sports-related injuries in emergency departments yearly. These injuries frequently result from falls, collisions, and overexertion during unofficial sporting events or recreational athletic events. Besides, several sports injuries, including ligament rips and joint dislocations, need surgical procedures that use biosurgery products to promote a speedy and efficient recovery. Moreover, in sports medicine, these products are essential for accelerating recovery and getting players back to their best. As interest in sports continues to grow at amateur and professional levels, the frequency of injuries requiring surgical intervention will increase demand for biosurgery devices specifically designed for sports-related treatments in this sector.

Biosurgery Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product, source, application and end user.

Breakup by Product:

  • Bone-Graft Substitutes
  • Soft-Tissue Attachments
  • Hemostatic Agents
  • Surgical Sealants and Adhesives
  • Adhesion Barriers
  • Staple Line Reinforcement

Bone-graft substitutes account for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the product. This includes bone-graft substitutes, soft-tissue attachments, hemostatic agents, surgical sealants and adhesives, adhesion barriers, and staple line reinforcement. According to the report, bone-graft substitutes represented the largest segment.

Bone-graft substitutes are crucial alternatives to bone grafting. These stand-ins play a critical role in many surgical operations, supporting bone regeneration and repair in orthopedics, trauma, spine surgery, and dentistry applications. They are intended to minimize the risk of donor site morbidity and infection by promoting bone development and replacing conventional autografts, which require removing bone from the patient's own body. Furthermore, the expansion is driven by the increasing frequency of bone and joint problems, the need for less intrusive operations, and developments in biomaterial technology. The growth of this market segment is also fueled by the creation of novel synthetic and composite grafts with improved osteoconductive and osteoinductive qualities. For instance, on 23 May 2023, Royal Biologics, Inc., a company focused on advanced cellular and autologous technologies for improved surgical outcomes, unveiled BIO-REIGN 3D. This innovative bone graft substitute is the first to use a natural hyper-crosslinked carbohydrate polymer. It is designed to enhance bone grafting procedures, and this proprietary technology is introduced alongside Royal Biologics' licensing agreement for Molecular Matrix's patented Osteo-P BGS technology.

Breakup by Source:

  • Natural/Biologics Products
  • Synthetic Products

Natural/biologics products hold the largest share of the industry

A detailed breakup and analysis of the market based on the source have also been provided in the report. This includes natural/biologics products and synthetic products. According to the report, natural/biologics products accounted for the largest market share.

According to the biosurgery market overview, natural/biologics represent the largest segment due to their effective healing properties and biocompatibility. These products, derived from substances that are naturally present in the human body or other biological sources, include fibrin sealants, collagen-based matrices, and chitosan-based solutions. Additionally, natural/biologics product's ability to mimic natural physiological processes significantly reduces the risk of rejection and adverse reactions, making them highly preferred in surgical procedures. Moreover, market dominance is further supported by advancements in biotechnology that enhance the safety and efficacy of these materials. Consequently, the increasing demand for minimally invasive surgeries, coupled with the growing prevalence of chronic diseases requiring complex surgeries, continues to drive the growth of natural/biologics products in the market.

Breakup by Application:

  • Orthopedic Surgery
  • General Surgery
  • Neurological Surgery
  • Cardiovascular Surgery
  • Gynecological Surgery
  • Others

Neurological surgery represents the leading market segment

The report has provided a detailed breakup and analysis of the market based on the application. This includes orthopedic surgery, general surgery, neurological surgery, cardiovascular surgery, gynecological surgery, and others. According to the report, neurological surgery represented the largest segment.

Neurological surgeries are complex and require critical precision. Additionally, biosurgery products, such as sealants, hemostatic agents, and adhesion barriers, are extensively used in neurological procedures to manage bleeding, seal tissues, and reduce post-operative complications. Moreover, the rising prevalence of neurological disorders, such as brain tumors, epilepsy, and Parkinson's disease, coupled with advancements in neurosurgical techniques are escalating the demand in this segment. Besides, the widespread adoption of minimally invasive (MI) surgeries, which require highly effective biosurgical solutions to enhance patient outcomes is further driving the biosurgery market growth. This trend is supported by technological innovations in biosurgery products, aimed at improving surgical outcomes and reducing recovery times.

Breakup by End User:

  • Hospitals
  • Clinics
  • Others

Hospital exhibits a clear dominance in the market

A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes hospitals, clinics, and others. According to the report, hospitals accounted for the largest market share.

Hospitals offer a wide array of surgical procedures that frequently utilize biosurgical products. These products, which include hemostatic agents, surgical sealants, and adhesives, are integral in managing intraoperative and postoperative bleeding and promoting tissue healing. Additionally, hospitals' capacity to handle high patient volumes and conduct complex surgeries increases biosurgery demand. Additionally, the constant advancements in surgical techniques and the increasing preference for minimally invasive surgeries further amplify the utilization of biosurgical solutions in hospital settings.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest biosurgery market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest regional market for biosurgery.

North America is the leading region due to the advanced healthcare infrastructure, significant investments in research and development (R&D) activities, and the presence of leading players who drive innovation and expansion. Additionally, the increasing prevalence of chronic diseases and the growing elderly population in North America contribute to a higher demand for biosurgical products. According to the biosurgery market forecast, these factors, combined with favorable government policies and a strong trend toward minimally invasive surgeries, will continue to strengthen North America's leading position in the global biosurgery market.

Competitive Landscape:

  • The biosurgery market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the industry include B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, CryoLife Inc., CSL Limited, Hemostasis LLC, Integra Lifesciences Holdings Corporation, Johnson & Johnson, Medtronic plc, Pfizer Inc., Sanofi S.A., Smith & Nephew plc, Stryker Corporation and Surgalign Spine Technologies Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

  • At present, biosurgery market players are actively enhancing market growth through a combination of strategic collaborations, innovative product launches, and expansions into new geographical markets. These companies invest heavily in research and development (R&D) to introduce advanced products that meet the increasing demands of minimally invasive surgeries and improved wound care. Additionally, market players are focusing on obtaining regulatory approvals across different regions, which helps in expanding their global footprint and accessing new markets. These strategies collectively contribute to the robust growth and resilience of the biosurgery market. For instance, in 2023, AROA Biosurgery Ltd. revealed the release of a new retrospective pilot case series that explores the use of Myriad Matrix and Myriad Morcells in the surgical treatment of contaminated volumetric soft tissue defects. It reviewed 13 complex traumatic wounds in 10 patients at a single facility. The study reported an average time of 23.4+-9.2 days for achieving soft tissue coverage and fill, with a median of one product application and no complications among participants. Moreover, the research focused on injuries from motor vehicle accidents, abdominal dehiscence after hernia repair, Fournier's Gangrene, compartment syndrome, and pressure injuries at a US Level 1 trauma center. It found that the Myriad products facilitated effective soft tissue formation with no reported complications, reinforcing the utility of AROA ECM products in trauma care.

Biosurgery Market News:

  • November 2023, Ethicon, a Johnson & Johnson MedTech company, has announced the approval of ETHIZIA, a hemostatic solution shown to provide effective and lasting control of severe bleeding in challenging situations. This new hemostatic patch enhances Ethicon's extensive biosurgery range and strengthens its capability to meet urgent needs in bleeding control.

Key Questions Answered in This Report:

  • How has the global biosurgery market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global biosurgery market?
  • What is the impact of each driver, restraint, and opportunity on the global biosurgery market?
  • What are the key regional markets?
  • Which countries represent the most attractive biosurgery market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the biosurgery market?
  • What is the breakup of the market based on the source?
  • Which is the most attractive source in the biosurgery market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the biosurgery market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the biosurgery market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global biosurgery market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Biosurgery Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Bone-Graft Substitutes
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Soft-Tissue Attachments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Hemostatic Agents
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Surgical Sealants and Adhesives
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Adhesion Barriers
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Staple Line Reinforcement
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Source

  • 7.1 Natural/Biologics Products
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Synthetic Products
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Orthopedic Surgery
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 General Surgery
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Neurological Surgery
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Cardiovascular Surgery
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Gynecological Surgery
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 B. Braun Melsungen AG
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 SWOT Analysis
    • 15.3.2 Baxter International Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Becton Dickinson and Company
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 CryoLife Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 CSL Limited
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Hemostasis LLC
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Integra Lifesciences Holdings Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Johnson & Johnson
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Medtronic plc
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Pfizer Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Sanofi S.A.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Smith & Nephew plc
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis
    • 15.3.13 Stryker Corporation
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
      • 15.3.13.4 SWOT Analysis
    • 15.3.14 Surgalign Spine Technologies Inc.
      • 15.3.14.1 Company Overview
      • 15.3.14.2 Product Portfolio
      • 15.3.14.3 Financials

List of Figures

  • Figure 1: Global: Biosurgery Market: Major Drivers and Challenges
  • Figure 2: Global: Biosurgery Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Biosurgery Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Biosurgery Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Biosurgery Market: Breakup by Source (in %), 2023
  • Figure 6: Global: Biosurgery Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Biosurgery Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Biosurgery Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Biosurgery (Bone-Graft Substitutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Biosurgery (Bone-Graft Substitutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Biosurgery (Soft-Tissue Attachments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Biosurgery (Soft-Tissue Attachments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Biosurgery (Hemostatic Agents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Biosurgery (Hemostatic Agents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Biosurgery (Surgical Sealants and Adhesives) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Biosurgery (Surgical Sealants and Adhesives) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Biosurgery (Adhesion Barriers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Biosurgery (Adhesion Barriers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Biosurgery (Staple Line Reinforcement) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Biosurgery (Staple Line Reinforcement) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Biosurgery (Natural/Biologics Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Biosurgery (Natural/Biologics Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Biosurgery (Synthetic Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Biosurgery (Synthetic Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Biosurgery (Orthopedic Surgery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Biosurgery (Orthopedic Surgery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Biosurgery (General Surgery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Biosurgery (General Surgery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Biosurgery (Neurological Surgery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Biosurgery (Neurological Surgery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Biosurgery (Cardiovascular Surgery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Biosurgery (Cardiovascular Surgery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Biosurgery (Gynecological Surgery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Biosurgery (Gynecological Surgery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Biosurgery (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Biosurgery (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Biosurgery (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Biosurgery (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Biosurgery (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Biosurgery (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Global: Biosurgery (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Global: Biosurgery (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: North America: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: North America: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: United States: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: United States: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Canada: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Canada: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Asia-Pacific: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Asia-Pacific: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: China: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: China: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Japan: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Japan: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: India: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: India: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: South Korea: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: South Korea: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Australia: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Australia: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Indonesia: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Indonesia: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Others: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Others: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Europe: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Europe: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Germany: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Germany: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: France: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: France: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: United Kingdom: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: United Kingdom: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Italy: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Italy: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Spain: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Spain: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Russia: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Russia: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Others: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Others: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Latin America: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Latin America: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Brazil: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Brazil: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Mexico: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Mexico: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Others: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 88: Others: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Middle East and Africa: Biosurgery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 90: Middle East and Africa: Biosurgery Market: Breakup by Country (in %), 2023
  • Figure 91: Middle East and Africa: Biosurgery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 92: Global: Biosurgery Industry: SWOT Analysis
  • Figure 93: Global: Biosurgery Industry: Value Chain Analysis
  • Figure 94: Global: Biosurgery Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Biosurgery Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Biosurgery Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Biosurgery Market Forecast: Breakup by Source (in Million US$), 2024-2032
  • Table 4: Global: Biosurgery Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Biosurgery Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Biosurgery Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Biosurgery Market: Competitive Structure
  • Table 8: Global: Biosurgery Market: Key Players